Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis: A prospective study

Archives of Internal Medicine

Volumn 157, Issue 3, 1997, Pages 305-308

  Pacouret, Gérard ^a,c   Alison, Daniel ^b   Pottier, Jean Marie ^c   Bertrand, Philippe ^b   Charbonnier, Bernard ^a  

^a Cardiology D and Coronary Care Unit   (France)

^b Department of Radiology ^*  (France)

^c SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0031021667     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.3.305     Document Type: Article

References (19)

1. Miller GAH, Sutton GC, Kerr IH, Gibson RV, Honey M. Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. BMJ. 1971;2:681-686.
2. Norussis MJ. SPSS for Windows Base System User's Guide, Release 5.0. Chicago, III: SPSS Inc; 1992.
3. Radomski JS, Jarrell BE, Carabasi RA, Yang SK, Koolpe H. Risk of pulmonary embolism with inferior vena thrombosis. Am Surg. 1987;53:97-101.
4. Balridge ED, Martin MA, Welling RE. Clinical significance of free-floating venous thrombi. J Vasc Surg, 1990;11:62-69.
5. Girard P, Hanuy MP, Musset D, Simonneau G, Petitpretz P. Acute inferior vena cava thrombosis: early results of heparin therapy. Chest. 1989;95:284-291.
6. Monreal M, Ruiz J, Salvador R, Morera J, Arias A. Recurrent pulmonary embolism: a prospective study. Chest. 1989;95:976-979.
7. Berry RE, George JE, Shaver WA. A free-floating deep venous thrombosis. Ann Surg. 1990;211:719-722.
8. Norris CS, Greenfield LJ, Herrmann JB. Free-floating ilio-femoral thrombus: a risk of pulmonary embolism. Arch Surg. 1985;120:806-808.
9. Browse NL, Thomas ML. Source of non-lethal pulmonary emboli. Lancet. 1974;1:258-259.
10. Voet BD, Afschrift M. Floating thrombi: diagnosis and follow-up by duplex ultrasound. Br J Radiol. 1991;64:1010-1014.
11. Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet. 1960;1:1309-1312.
12. Hull R, Delmore T, Genton E, et al. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med. 1979;301:855-858.
13. Levine M, Gent M, Hirsh J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med. 1996;334:677-681.
14. Koopman MMW, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med. 1996;334:682-687.
15. Carabasi RA, Moritz MJ, Jarrell BE. Complications encountered with the use of the Greenfield filter. Am J Surg. 1987;154:163-168.
16. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. JAMA. 1990;263:2753-2759.
17. Moser KM, Longe AM, Ashburn WL, Guisan M. Suprious scintiphotographic recurrence of pulmonary emboli. Am J Med. 1973;55:434-443.
18. Leizorovicz A, Simonneau G, Decousus H, Boissel JP. Comparison of efficacy and safety of low-molecular-weight heparins and unfractionated heparin in the initial treatment of deep venous thrombosis. BMJ. 1994;309:299-304.
19. Hull R, Raskob G, Hirsh J, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal vein thrombosis. N Engl J Med. 1986;315:1109-1114.